scholarly journals Epidemiological and Immunological Efficacy of Health Workers Vaccination against Hepatitis B

2017 ◽  
Vol 16 (4) ◽  
pp. 52-57 ◽  
Author(s):  
V. G. Akimkin ◽  
T. A. Semenenko
Keyword(s):  
Hepatitis B ◽  
Medical Staff ◽  
Health Workers ◽  
Protective Level ◽  
Clinical Forms ◽  
Vaccination Scheme

The results of specific immunization of hospital health workers with domestic hepatitis B «Combiotech» vaccine indicate its high immunological and epidemiological efficiency. Protective level of collective immunity was established during surveillance according to the standard vaccination scheme, and epidemiological protectability over a period of the emergency vaccination scheme with the threat of professional infection. The marked lack of hepatitis B cases among vaccinated persons when carrying out immunization according to standard and emergency schemes as well as a significant reduction of the morbidity of medical staff of various clinical forms of the infection got registered. Use of domestic preparation taking into account two serotypes of ayw and adw which are contained in vaccines against hepatitis B is advisable.

scholarly journals ПРОФЕССИОНАЛЬНАЯ ЗАБОЛЕВАЕМОСТЬ МЕДИЦИНСКИХ РАБОТНИКОВ ПРИМОРСКОГО КРАЯ (2005-2014 ГГ.)

2019 ◽  
Vol 96 (3) ◽  
pp. 258-260
Author(s):  
M. V. Bektasova ◽  
V. A. Kaptsov ◽  
A. A. Sheparev
Keyword(s):  
Hepatitis B ◽  
Viral Hepatitis ◽  
Medical Staff ◽  
Health Workers ◽  
Medical Personnel ◽  
Morbidity Rate ◽  
Primorsky Krai ◽  
Latex Gloves ◽  
Medical Institutions ◽  
Viral Hepatitis B

The level of occupational morbidity rate of medical workers in governmental and multidisciplinary infectious medical institutions of the Primorsky Krai was studied according to reporting forms for the period of 2005-2014. The aim of the study was to investigate occupational morbidity rate of medical personnel to improve the management of health workers and to develop preventive programs for its reduction. Annual surveys of the medical staff for the carriage of viral hepatitis B, C, vaccinal prevention of hepatitis B; reduction of the use of chlorine-containing disinfectants; replacing latex gloves by nitrile, vinyl hypoallergenic medical gloves to protect hands of personnel allowed to significantly reduce the occupational morbidity rate.

Eliminating Hepatitis B from Bangladesh by the Year 2030

2020 ◽  
Vol 38 (3) ◽  
pp. 145-149
Author(s):  
Md Golam Mustafa ◽  
Md Shahinul Alam ◽  
Md Golam Azam ◽  
Md Mahabubul Alam ◽  
Md Saiful Islam ◽  
...  
Keyword(s):  
Hepatitis B ◽  
Health Workers ◽  
Health Sector ◽  
Public Health Problem ◽  
Integrated System ◽  
Hbv Infection ◽  
Diagnosis And Treatment ◽  
Major Public Health Problem ◽  
Medical Institutions ◽  
The Government

Worldwide, hepatitis B virus (HBV) infection is still a major public health problem. Bangladesh having a large burden of HBV infection, should be a major contributor towards it’s elimination by 2030. The country has been making progress in reducing incidence of HBV infection during the past decades. The progresses are mainly due to large vaccination coverage among children and large coverage of timely birthdose vaccine for prevention of mother-to-child transmission of HBV. However, Bangladesh still faces challenges in achieving target of reduction in mortality from HBV. On the basis of targets of the WHO’s Global health sector strategy on viral hepatitis 2016–2021, we highlight priorities for action towards HBV elimination. To attain the target of reduced mortality we propose that, the service coverage targets of diagnosis and treatment should be prioritized along with vaccination. Firstly, improvements are needed in the diagnostic and treatment abilities of medical institutions and health workers. Secondly, the government needs to reduce the costs of health care. Thirdly, better coordination is needed across existing national program and resources to establish an integrated system for prevention, screening, diagnosis and treatment of HBV infection. In this way, we can make progress towards achieving the target of eliminating HBV from Bangladesh by 2030 J Bangladesh Coll Phys Surg 2020; 38(3): 145-149

The Efficacy of a Two-Dose Hepatitis B Vaccination Scheme

2003 ◽  
pp. 185-190 ◽  
Author(s):  
Greet J. Boland ◽  
Toon van Bommel ◽  
Annemarie Rulos van den Berg ◽  
Jan P. B. van den Berg ◽  
Anton M. van Loon ◽  
...  
Keyword(s):  
Hepatitis B ◽  
Hepatitis B Vaccination ◽  
Vaccination Scheme

Hepatitis B Vaccine in Healthy Hospital Employees

1986 ◽  
Vol 7 (7) ◽  
pp. 365-369 ◽  
Author(s):  
S.A Klotz ◽  
R. Normand ◽  
R. Silberman
Keyword(s):  
Hepatitis B ◽  
Surface Antigen ◽  
Response Rate ◽  
Hepatitis B Surface Antigen ◽  
Hepatitis B Vaccine ◽  
Protective Level ◽  
Entire Series ◽  
Hospital Employees ◽  
Lower Response Rate ◽  
Low Rate

AbstractA low rate of seroconversion to hepatitis B vaccine is reported. This occurred in healthy hospital employees from two separate institutions. A total of 236 individuals were evaluated in this study and only 53% or 124 persons developed protective levels of antibody to hepatitis B surface antigen following a complete vaccine series. In one hospital, 30% of the vaccine recipients developed antibody but not to a protective level. Employees who received the entire series in the arm or in the arm and buttock (mixed) had a significantly greater number of responders than employees who received the entire series in the buttock (P<.05). Recipients aged 50 to 59 years had a significantly lower response rate to the vaccine (P<.05). There was no correlation with the vaccinee's sex or the timing of the second injection. Vaccine was noted to have frozen in one hospital and accounted for some loss of antigenicity. This failure to respond to the vaccine has necessitated the use of booster injections of vaccine and continued antibody monitoring.

Response to a reinforced hepatitis B vaccination scheme in HIV-infected patients under real-life conditions

Vaccine ◽  
2019 ◽  
Vol 37 (20) ◽  
pp. 2758-2763 ◽  
Author(s):  
Karin Neukam ◽  
Alicia Gutiérrez-Valencia ◽  
Silvia Llaves-Flores ◽  
Nuria Espinosa ◽  
Pompeyo Viciana ◽  
...  
Keyword(s):  
Hepatitis B ◽  
Real Life ◽  
Hepatitis B Vaccination ◽  
Life Conditions ◽  
Vaccination Scheme

scholarly journals Is vaccination against hepatitis B a reality among Primary Health Care workers?

2013 ◽  
Vol 21 (1) ◽  
pp. 316-324 ◽  
Author(s):  
Fernanda Marques da Costa ◽  
Andréa Maria Eleutério de Barros Lima Martins ◽  
Pedro Eleutério dos Santos Neto ◽  
Duran Nunes de Pinho Veloso ◽  
Vilma Soares Magalhães ◽  
...  
Keyword(s):  
Health Care ◽  
Primary Health Care ◽  
Hepatitis B ◽  
Occupational Health ◽  
Health Care Workers ◽  
Professional Education ◽  
Older Workers ◽  
Primary Health ◽  
Vaccination Scheme ◽  
Care Workers

OBJECTIVE: To verify the prevalence and factors associated with vaccination against hepatitis B among Primary Health Care workers in Montes Claros/MG. METHOD: A cross-sectional, analytic study was undertaken. Data were collected through a form, which contained sociodemographic, occupational, general health and behavioral variables. Associations were investigated through bivariate analysis and Poisson's multivariate regression, using SPSS 17.0. RESULTS: 95.5% answered the question about vaccination; 47.5% did not complete the vaccination scheme. The prevalence of vaccinated professionals was lower among older workers, who were hired, did not participate in occupational health updates and consumed alcohol. Prevalence levels were higher among professionals with more years of education and who reported contact with piercing and cutting instruments . CONCLUSIONS: Professional education, knowledge and perception of infection risks are important determinants of the vaccination scheme. Instability at work may lead to negligence and negligent behaviors may repeat themselves. The characterization of professionals who did not get vaccinated will direct educative actions in occupational health.

scholarly journals Seroconversion after Recombinant Hepatitis B Vaccination

1970 ◽  
Vol 11 (2) ◽  
pp. 143-150 ◽  
Author(s):  
Abhijit Guho ◽  
Md Abdul Ahad ◽  
Md Abdus Salam ◽  
Md Abdul Alim ◽  
AKM Enamul Haque ◽  
...  
Keyword(s):  
Hepatitis B Virus ◽  
Virus Infection ◽  
Hepatitis B ◽  
Hepatitis B Vaccine ◽  
Hepatitis B Virus Infection ◽  
Recombinant Hepatitis ◽  
Protective Level ◽  
Significant Difference ◽  
B Virus ◽  
Study Population

Background: Hepatitis B virus infection is an important public health problem with significant morbidity andmortality. Recombinant hepatitis B vaccine for the prevention of hepatitis B virus infection is in practice in differentparts of the world since its availability in 1986. Government of Bangladesh has also included hepatitis B vaccine inEPI schedule since 2005.Materials and methods: This study was carried out to assess the seroconversion status among hepatitis Bvaccinated individuals. A total of 190 individuals including 150 vaccinated persons and 40 non-vaccinated apparentlyhealthy individuals were included as study population. Sources of vaccinated persons were from both EPI and non-EPI schedule of vaccination. Age and sex matched non-vaccinated individuals served as controls for the study. Allindividuals constituting the study population were screened for HBsAg by Immunochromatographic strip test andonly HBsAg-negative persons were included for estimation of their anti-HBs titer.Results: Out of 150 vaccinated individuals, 133(88.67%) were found to have anti-HBs titer in the protective level(>10 IU/L), while 17(11.33%) individuals had anti-HBs titer below the protective level (<10 IU/L). All non-vaccinatedcontrols had anti-HBs titers below the protective level. Regarding immune response developed among vaccinatedindividuals, 67.78%, 23.33% and 8.89% were good-responders, hypo-responders and non-responders respectively.Mean titer of anti-HBs was found significantly higher among recipients who received booster dose than those whoreceived 3 doses schedule (863.39 IU/L vs. 262.40 IU/L), indicating high antibody titer develops after booster dose.Vaccinated group included 85 (56.67%) men and 65 (43.33%) women with protective level of anti-HBs titer foundin 85.88% male and 92.31% female individuals. There was no significant difference of anti-HBs titer between maleand female (p>0.05). Vaccinated individuals from lower socioeconomic condition have had comparatively low rateof protective antibody than people from middle and upper classes.Conclusion: Recombinant HB vaccine induces good level of protective immunity among vaccinated persons.Keywords: Hepatitis B; hepatitis B vaccine; seroconversion; BangladeshDOI: 10.3329/jom.v11i2.5461J MEDICINE 2010; 11 : 143-150

Infectivity of medical staff for hepatitis B

Infection ◽  
1988 ◽  
Vol 16 (3) ◽  
pp. 171-174 ◽  
Author(s):  
H. Hofmann ◽  
W. Tuma ◽  
F. X. Heinz ◽  
W. Frisch-Niggemeyer ◽  
C. Kunz
Keyword(s):  
Hepatitis B ◽  
Medical Staff
Sign in / Sign up

Export Citation Format

Share Document